Abstract
Treatment of patients having myelodysplastic a syndromes (MDS) with approaches such as differentiation induction, single cytostatic agents or supportive care only has, up to now, been rather unsuccessful. Aggressive chemotherapy followed by bone marrow transplantation is only suitable for a very small proportion of patients. Thus, there is a need for new therapeutic alternatives.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Platzer E, Welte K, Gabrilove JL, Harris P, Mertelsmann R, Moore MAS (1985) Biological activities of a human pluripotent hemopoietic colony stimulating factor on normal and leukemic cells. J Exp Med 162: 1788–1801
Griffin JD, Young D, Herrmann F, Wiper D, Wagner K, Sabbath KD (1986) Effects of recombinant human GM-CSF on proliferation of clonogenic cells in acute myeloblasts leukemia. Blood 67: 1448–1453
Griffin JD, Löwenberg B (1986) Clonogenic cells in acute myeloblasts leukemia. Blood 68: 1185–1195
Souza LM, Boone TC, Gabrilove J, et al. (1986) Recombinant pluripotent human granulocyte colony-stimulating factor: effectson normal and leukemic myeloid cells. Science 232: 61–65
Kelleher C, Miyauchi J, Wong G, Clark S, Minden MD, McCulloch EA (1987) Synergism between recombinant growth factors, GM-CSF and G-CSF, acting on the blast cells of acute myeloblasts leukemia. Blood 69: 1498–1503
Vadhan-Raj S, Keating M, LeMaistre A, et al. (1987) Effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes. N Engl J Med 317: 1545 - 1552
Antin JH, Smith BR, Holmes W, Rosenthal DS (1988) Phase I/II study of recombinant human granulocyte-macrophage colonystimulating factor in aplastic anemia and myelodysplastic syndromes. Blood 72: 705–713
Thompson J, Lee D, Rubin E, Kaufmann J, Bonnern E, Fefer A (1988) Treatment of myelodysplastic syndrome (MDS) with subcutaneous (SC) recombinant granulocytemacrophage colony-stimulating factor (rGMCSF). Blood 72 [Suppl]: 230a
Ganser A, Völkers B, Greher J, et al. (1989) Recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndrome - a phase I/II trial. Blood 73: 31–37
Estey E, Kurzrock R, Talpaz M, et al. (1989) Therapy of myelodysplastic syndromes ( MDS) with GM-CSF. Proc Am Soc Clin Oncol 8: 200
Hoelzer D, Ganser A, Völkers B, Greher J, Walther F (1988) In vitro and in vivo action of recombinant human GM-CSF (rhGMCSF) in patients with myelodysplastic syndromes. Blood Cells 14: 551–558
Hittelmann WN, Agbor P, Petkorie I, et al. (1988) Detection of leukemic clone maturation in vivo by premature chromosome condensation. Blood 72: 1950–1960
Cantrell MA, Anderson D, Ceretti D, et al. (1985) Cloning, sequence, and expression of a human granulocyte-macrophage colony-stimulating factor. Proc Natl Acad Sci USA 82: 6250–6254
Bennett JM, Catovsky D, Daniel MT, et al. (1982) Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 51: 189–199
Cheson BD, Simon R (1987) Low-dose ara-C in acute nonlymphocytic leukemia and myelodysplastic syndromes: a review of 20 years experience. Semin Oncol 14 [Suppl]: 126–133
Bolwell BJ, Cassileth PA, Gale RP (1987) Low dose cytosine arabinoside in myelodysplasia and acute myelogenous leukemia: a review. Leukemia 1: 575–579
Andreeff M, Hegewisch-Becker S, Tefurin A, et al. (1989) Recruitment of leukemic cells in vitro by colony-stimulating factors (G-CSF, GM-CSF, Interleukin-3): Evidence of increased cell kill and of differentiation by highland low-dose cytosine-arabinoside. Blut (inpress )
Hegewisch S, Harini J, Bressler J, et al. (1989) Induction of differentiation by recombinant human granulocyte and granulocyte-macrophage growth factors and cytosine arabinoside in the human myeloid cell line KG1. Leukemia (in press)
De Witte T, Muus P, Haanen C, et al. (1988) GM-CSF enhances sensitivity of leukemic clonogenic cells to long-term low dose cytosine arabinoside with sparing of the normal clonogenic cells. Behring Inst Mitt 83: 301–307
Ganser A, Völkers B, Greher J, et al. (1989) Treatment of patients with myelodysplastic syndromes with recombinant human granulocyte-macrophage colony-stimulating factors — a phase I/II trial. (in press)
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Hoelzer, D. et al. (1990). Effect of Treatment with rhGM-CSF and Low-Dose Cytosine Arabinoside on Leukemic Blast Cells in Patients with Myelodysplastic Syndromes. In: Büchner, T., Schellong, G., Hiddemann, W., Ritter, J. (eds) Acute Leukemias II. Haematology and Blood Transfusion / Hämatologie und Bluttransfusion, vol 33. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-74643-7_138
Download citation
DOI: https://doi.org/10.1007/978-3-642-74643-7_138
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-50984-4
Online ISBN: 978-3-642-74643-7
eBook Packages: Springer Book Archive